Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Blood|December 10, 2014
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cellsJonathan Reichel, Amy Chadburn, Paul G Rubinstein, et al.
Clinical Chemistry|April 29, 2021
TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody DurabilitySabrina E Racine-Brzostek, Mohsen Karbaschi, Christian Gaebler, et al.
The Journal of Pathology|August 7, 2010
Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migrationShi-Lu Luan, Emmanuelle Boulanger, Hongtao Ye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphomaJohn P Leonard, Morton Coleman, Jamie Ketas, et al.
Nature Genetics|August 2, 2011
Analysis of the coding genome of diffuse large B-cell lymphomaLaura Pasqualucci, Vladimir Trifonov, Giulia Fabbri, et al.
Health Data Science|November 21, 2022
Machine Learning Highlights Downtrending of COVID-19 Patients with a Distinct Laboratory ProfileHe S Yang, Yu Hou, Hao Zhang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 8, 2020
SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassaysHe S Yang, Sabrina E Racine-Brzostek, William T Lee, et al.
Nature Immunology|August 4, 2009
HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduitsWeifeng Xu, Paul A Santini, John S Sullivan, et al.
Haematologica|December 3, 2011
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtypeWyndham H Wilson, Sin-Ho Jung, Pierluigi Porcu, et al.
The American Journal of Surgical Pathology|November 2, 2020
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological TherapyAliyah R Sohani, Matthew J Maurer, Sharmila Giri, et al.
Pageof 18